The purposes of this study is to compare the test products Salmeterol/fluticasone Easyhaler with marketed product Seretide Diskus in terms of the drug absorbed into the blood stream
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
129
Orion Pharma Pharmacology Unit
Espoo, Finland
Cmax of plasma salmeterol and fluticasone propionate
Time frame: within 34 h
AUCt of plasma salmeterol and fluticasone propionate
Time frame: 34 h
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.